Research progress on antitumor mechanism of bufalin

Fajiang MAO; Haiyan HUANG; Ling ZUO

doi:10.16305/j.1007-1334.2022.2104007

您当前的位置：

首页 >

文章列表页 >

Research progress on antitumor mechanism of bufalin

更新时间：2022-07-10

- Research progress on antitumor mechanism of bufalin
- Shanghai Journal of Traditional Chinese Medicine Vol. 56, Issue 2, Pages: 87-90(2022)
- 作者机构：
  
  1.上海中医药大学附属市中医医院（上海 200071）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2022.2104007
  CLC：
扫描看全文
毛发江,黄海燕,左玲.蟾毒灵抗肿瘤作用机制的研究进展[J].上海中医药杂志,2022,56(02):87-90.

MAO Fajiang,HUANG Haiyan,ZUO Ling.Research progress on antitumor mechanism of bufalin[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(02):87-90.
毛发江,黄海燕,左玲.蟾毒灵抗肿瘤作用机制的研究进展[J].上海中医药杂志,2022,56(02):87-90. DOI： 10.16305/j.1007-1334.2022.2104007.

MAO Fajiang,HUANG Haiyan,ZUO Ling.Research progress on antitumor mechanism of bufalin[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(02):87-90. DOI： 10.16305/j.1007-1334.2022.2104007.

摘要

阐述近年来蟾毒灵抗肿瘤作用具体机制的研究进展。蟾毒灵抗肿瘤的机制主要体现在诱导肿瘤细胞凋亡、抑制肿瘤细胞增殖、抑制肿瘤血管形成等方面，同时以蟾毒灵为基础衍生的抗肿瘤药物可以优化蟾毒灵的抗肿瘤作用，减少其副作用。

Abstract

This paper reviews the research progress on the specific mechanism of the antitumor effect of bufalin in recent years. The antitumor mechanism of bufalin is mainly reflected in the induction of tumor cell apoptosis， inhibition of tumor cell proliferation and tumor angiogenesis and so on. And the antitumor drugs derived from bufalin can optimize the antitumor effect of bufalin， and reduce side effects.

关键词

蟾毒灵抗肿瘤作用机制综述

Keywords

bufalinantitumormechanism of actionreview

references

LI M， WANG X J， ZHAO Q， et al. Bufalin-induced cardiotoxicity： new findings into mechanisms［J］. Chin J Nat Med， 2020， 18（7）： 550-560.

ZHANG X， ZHAO X， LIU K， et al. Bufalin： a systematic review of research hotspots and antitumor mechanisms by text mining and bioinformatics［J］. Am J Chin Med， 2020， 48 （7）： 1633-1650.

QIAN L， SU H， WANG G， et al. Anti-tumor activity of bufalin by inhibiting c-MET mediated MEK/ERK and PI3K/AKT signaling pathways in gallbladder cancer［J］. J Cancer， 2020， 11 （11）： 3114-3123.

LI F J， HU J H， REN X， et al. Toad venom： a comprehensive review of chemical constituents， anticancer activities， and mechanisms［J］. Arch Pharm （Weinheim）， 2021， 354 （7）： e2100060.

ZHANG J， HONG Y， XIE P， et al. Spatial lipidomics reveals anticancer mechanisms of bufalin in combination with cinobufagin in tumor-bearing mice［J］. Front Pharmacol， 2020（11）： 593815.

PAN L， NIE L， YAO S， et al. Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species-mediated apoptosis by targeting the electron transport chain［J］. Int J Mol Med， 2020， 46 （6）： 2137-2149.

LINGHU H R， LUO H， GANG L. Bufalin induces glioma cell death by apoptosis or necroptosis［J］. Onco Targets Ther， 2020（13）： 4767-4778.

QI H Y， QU X J， LIU J， et al. Bufalin induces protective autophagy by Cbl-b regulating mTOR and ERK signaling pathways in gastric cancer cells［J］. Cell Biol Int， 2019， 43 （1）： 33-43.

LIU J， ZHANG Y， SUN S， et al. Bufalin induces apoptosis and improves the sensitivity of human glioma stem-like cells to temozolamide［J］. Oncol Res， 2019， 27 （4）： 475-486.

CHEN J， WANG H， JIA L， et al. Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer［J］. Cancer Lett， 2021 （513）： 63-74.

XIE Y， YAN X， SUN L. The mechanism of bufalin-induced apoptosis of K562/A02［J］. Med Sci Monit， 2019（25）： 2542-2552.

GU R， ZHANG Q. Effects of low-dose bufalin combined with hydroxycamptothecin on human castration-resistant prostate cancer xenografts in nude mice［J］. Exp Ther Med， 2021， 22 （3）： 1015.

郑凯，杨梅桂，闫朝君，等. 线粒体动力学与细胞凋亡［J］. 中国细胞生物学学报，2019， 41（8）： 1467-1476.

MENG Q， ZHAO Y， AN L， et al. Inhibitory effect of bufalin on retinoblastoma cells （HXO-RB44） via the independent mitochondrial and death receptor pathway［J］. Am J Transl Res， 2016， 8 （11）： 4968-4974.

WU D， ZHOU W Y， LIN X T， et al. Bufalin induces apoptosis via mitochondrial ROS-mediated caspase-3 activation in HCT-116 and SW620 human colon cancer cells［J］. Drug Chem Toxicol， 2019， 42 （4）： 444-450.

董倩倩，张俊萍. 蟾毒灵通过基质金属蛋白酶抑制人结肠癌细胞HCT116的侵袭和迁移［J］. 中医研究，2020， 33（3）： 76-80.

ZHANG J， SHA J， ZHOU Y， et al. Bufalin inhibits proliferation and induces apoptosis in osteosarcoma cells by downregulating microRNA-221［J/OL］. Evid Based Complement Alternat Med， 2016［2021-04-01］. https：//www.ncbi.nlm.nih.gov/pmc/articles/PMC5198087/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198087/.

石婷，张雯，周群，等. 蟾毒灵通过下调PKM2抑制黑色素瘤细胞增殖、迁移与侵袭的实验研究［J］. 药学与临床研究，2019， 27（5）： 327-331.

SU S， DOU H， WANG Z， et al. Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-alpha pathway［J］. Basic Clin Pharmacol Toxicol， 2021， 128 （2）： 224-233.

陈慧，聂雪珂，杨雅亭，等. 蟾毒灵对食管癌增殖的影响及机制研究［J］. 中国药学杂志，2020， 55（16）： 1346-1353.

李文玉，赵振峰，童铸廷. 蟾毒灵对人前列腺癌PC3细胞增殖及放疗敏感性影响的研究［J］. 世界最新医学信息文摘，2019， 19（46）： 1-3.

SUN X， NG T T H， SHAM K W Y， et al. Bufalin， a traditional Chinese medicine compound， prevents tumor formation in two murine models of colorectal cancer［J］. Cancer Prev Res （Phila）， 2019， 12 （10）： 653-666.

YANG L， ZHOU F， ZHUANG Y， et al. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway［J］. Br J Cancer， 2021， 124 （3）： 645-657.

JIN J， YAO Z， QIN H， et al. Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis［J］. Biotechnol Lett， 2021， 43（6）： 1229-1240.

SHENG X， ZHU P， ZHAO Y， et al. Effect of PI3K/AKT/mTOR signaling pathway on regulating and controlling the anti-invasion and metastasis of hepatoma cells by bufalin［J］. Recent Pat Anticancer Drug Discov， 2021， 16 （1）： 54-65.

HAN M， YANG G， LIN Q， et al. Determination of endogenous bufalin in serum of patients with hepatocellular carcinoma based on HPLC-MS/MS［J］. Front Oncol， 2019（9）： 1572.

ZOU D， SONG J， DENG M， et al. Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway［J］. FASEB J， 2021， 35 （5）： e21601.

WANG H， ZHANG C， NING Z， et al. Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling［J］. Int J Oncol， 2016， 48 （3）： 1229-1241.

翟笑枫，吕祥，顾伟，等. 蟾毒灵抑制血管生成作用的初步观察［J］. 中国中医药信息杂志，2010， 17（8）： 29-31.

LIU T， YUAN X， JIA T， et al. Polymeric prodrug of bufalin for increasing solubility and stability： synthesis and anticancer study in vitro and in vivo［J］. Int J Pharm， 2016， 506（1-2）： 382-393.

LEI M， XIAO Z， MA B， et al. Synthesis and biological evaluation of bufalin-3-yl nitrogen-containing-carbamate derivatives as anticancer agents［J］. Steroids， 2016（108）： 56-60.

Views

607

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Chaihu Shugan Powder on AMPK/SIRT3 signaling pathway in rats with functional dyspepsia

Research progress in anti⁃tumor clinical efficacy and mechanism of action of Sarcandrae Herba

Research progress on use of external therapy of traditional Chinese medicine in benign anorectal diseases

Mechanism of Yucan Granules improving podocyte damage and treating diabetic nephropathy

Acupuncture modulates expression of circHDAC2 in hippocampus of cerebral ischemia reperfusion injury rats against neurological damage

Related Author

No data

Related Institution

Gastroenterology Department，Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai University of Traditional Chinese Medicine

Sichuan Institute for Translational Chinese Medicine

Guangming Traditional Chinese Medicine Hospital， Shanghai Pudong New Area

Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

⁰